AtriCure, Inc.

NasdaqGM:ATRC

Market Cap

USD 1.59 B

Share Price

USD 30.72

Avg Daily Volume

556,966

Change (1 day)

-4.18%

Change (1 year)

31.34%

Change (YTD)

0.52%

AtriCure, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2025: -3.65%

AtriCure, Inc. EBITDA Margin is -3.65% for the Trailing 12 Months (TTM) ending March 31, 2025, a 14.29% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • AtriCure, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was -3.20%, a -44.37% change year over year.
  • AtriCure, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was -5.74%, a -57.85% change year over year.
  • AtriCure, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was -13.63%, a -15.93% change year over year.
  • AtriCure, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was -16.21%, a 17.38% change year over year.
Key Data
Date EBITDA Margin Net Income Margin EBT Margin Operating Income Margin